Cargando…

Reduced levels of pulmonary surfactant in COVID-19 ARDS

To provide novel data on surfactant levels in adult COVID-19 patients, we collected bronchoalveolar lavage fluid less than 72 h after intubation and used Fourier Transform Infrared Spectroscopy to measure levels of dipalmitoylphosphatidylcholine (DPPC). A total of eleven COVID-19 patients with moder...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schousboe, Peter, Ronit, Andreas, Nielsen, Henning B., Benfield, Thomas, Wiese, Lothar, Scoutaris, Nikolaos, Verder, Henrik, Berg, Ronan M. G., Verder, Povl, Plovsing, Ronni R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904856/ https://www.ncbi.nlm.nih.gov/pubmed/35260704 http://dx.doi.org/10.1038/s41598-022-07944-4

Ejemplares similares

Assessment of pulmonary surfactant in COVID-19 patients
por: Schousboe, Peter, et al.
Publicado: (2020)

Bronchopulmonary dysplasia predicted at birth by artificial intelligence
por: Verder, Henrik, et al.
Publicado: (2020)

Atypical lymphocytes in bronchoalveolar lavage fluid from patients with COVID-19 ARDS
por: Berg, Ronan M.G., et al.
Publicado: (2020)

Compartmental immunophenotyping in COVID-19 ARDS: A case series
por: Ronit, Andreas, et al.
Publicado: (2021)

Predicting respiratory distress syndrome at birth using a fast test based on spectroscopy of gastric aspirates: 2. Clinical part
por: Heiring, Christian, et al.
Publicado: (2019)

Therapeutic benefits of proning to improve pulmonary gas exchange in severe respiratory failure: focus on fundamentals of physiology
por: Berg, Ronan M. G., et al.
Publicado: (2021)

Pulmonary Surfactant in Adult ARDS: Current Perspectives and Future Directions
por: Dushianthan, Ahilanandan, et al.
Publicado: (2023)

Reliability of the mean flow index (Mx) for assessing cerebral autoregulation in healthy volunteers
por: Olsen, Markus H., et al.
Publicado: (2021)

Lipopolysaccharide infusion enhances dynamic cerebral autoregulation without affecting cerebral oxygen vasoreactivity in healthy volunteers
por: Berg, Ronan MG, et al.
Publicado: (2013)

Endotracheal Surfactant Combined With Budesonide for Neonatal ARDS
por: Deliloglu, Burak, et al.
Publicado: (2020)

Surfactant for the Treatment of ARDS in a Patient With COVID-19
por: Heching, Moshe, et al.
Publicado: (2021)

Co-aerosolized Pulmonary Surfactant and Ambroxol for COVID-19 ARDS Intervention: What Are We Waiting for?
por: Kumar, Pradeep
Publicado: (2020)

Discrepant Fibrinolytic Response in Plasma and Whole Blood during Experimental Endotoxemia in Healthy Volunteers
por: Ostrowski, Sisse R., et al.
Publicado: (2013)

Soluble ectodomain CD163 and extracellular vesicle-associated CD163 are two differently regulated forms of ‘soluble CD163’ in plasma
por: Etzerodt, Anders, et al.
Publicado: (2017)

LUCINACTANT, A SYNTHETIC SURFACTANT FOR TREATMENT OF COVID-19-ASSOCIATED ARDS
por: GUARDIA, CARLOS G, et al.
Publicado: (2022)

Exogenous pulmonary surfactant in COVID-19 ARDS. The similarities to neonatal RDS suggest a new scenario for an ‘old’ strategy
por: Bhatt, Reena M, et al.
Publicado: (2021)

Host Genetics and Antiviral Immune Responses in Adult Patients With Multisystem Inflammatory Syndrome
por: Ronit, Andreas, et al.
Publicado: (2021)

Severe COVID-19 ARDS Treated by Bronchoalveolar Lavage with Diluted Exogenous Pulmonary Surfactant as Salvage Therapy: In Pursuit of the Holy Grail?
por: Ruaro, Barbara, et al.
Publicado: (2022)

Surfactant replacement and open lung concept – Comparison of two treatment strategies in an experimental model of neonatal ARDS
por: Hilgendorff, Anne, et al.
Publicado: (2008)

Rapid test for lung maturity, based on spectroscopy of gastric aspirate, predicted respiratory distress syndrome with high sensitivity
por: Verder, Henrik, et al.
Publicado: (2016)

Adenosine as pulmonary vasodilator in ARDS
por: Molina, JM, et al.
Publicado: (1998)

Pulmonary vascular dysfunction in ARDS
por: Ryan, Donal, et al.
Publicado: (2014)

Pulmonary infections complicating ARDS
por: Luyt, Charles-Edouard, et al.
Publicado: (2020)

Use of exogenous pulmonary surfactant in acute respiratory distress syndrome (ARDS): Role in SARS-CoV-2-related lung injury
por: Cattel, Francesco, et al.
Publicado: (2021)

How to reduce cisatracurium consumption in ARDS patients: the TOF-ARDS study
por: Hraiech, Sami, et al.
Publicado: (2017)

Lipid profile modifications of the lung tissue and surfactant in a murine model of malaria associated ARDS
por: Scaccabarozzi, Diletta, et al.
Publicado: (2012)

Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps
por: De Luca, Daniele, et al.
Publicado: (2021)

Surfactant therapy for COVID-19 related ARDS: a retrospective case–control pilot study
por: Piva, Simone, et al.
Publicado: (2021)

Alveolar Tissue Fiber and Surfactant Effects on Lung Mechanics—Model Development and Validation on ARDS and IPF Patients
Publicado: (2021)

Pulmonary Surfactant: Biology and Therapy
por: Willson, Douglas F., et al.
Publicado: (2008)

Alveolar Epithelium and Pulmonary Surfactant
por: Mason, Robert J., et al.
Publicado: (2016)

Lung Protection Strategies during Cardiopulmonary Bypass Affect the Composition of Bronchoalveolar Fluid and Lung Tissue in Cardiac Surgery Patients
por: Maltesen, Raluca G., et al.
Publicado: (2018)

Hemodynamic profile of pulmonary hypertension (PH) in ARDS
por: Calcaianu, George, et al.
Publicado: (2017)

CT pulmonary angiography findings in HIV-infected patients referred for suspected pulmonary thrombo-embolic disease
por: Wiese, Diane, et al.
Publicado: (2022)

Circulating microparticle levels are reduced in patients with ARDS
por: Shaver, Ciara M., et al.
Publicado: (2017)

The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development
por: Scott, J Elliott
Publicado: (2004)

The Pulmonary Surfactant: Impact of Tobacco Smoke and Related Compounds on Surfactant and Lung Development
por: Scott, J Elliott
Publicado: (2004)

Veno-venous ECMO as a platform to evaluate lung lavage and surfactant replacement therapy in an animal model of severe ARDS
por: Qaqish, Robert, et al.
Publicado: (2020)

The Effect of Exogenous Surfactant on Moderate and Severe Stages of COVID-19 Induced ARDS: the Pilot Study of a Clinical Trial
por: Fani, Kamal, et al.
Publicado: (2021)

Correlation of Surfactant Protein-D (SP-D) Serum Levels with ARDS Severity and Mortality in Covid-19 Patients in Indonesia
por: Agustama, Alexander, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u63m5tdc0ghup8sppuk6l61sgu